104 related articles for article (PubMed ID: 9708941)
1. Histopathologic review of prostate biopsies from patients referred to a comprehensive cancer center: correlation of pathologic findings, analysis of cost, and impact on treatment.
Wurzer JC; Al-Saleem TI; Hanlon AL; Freedman GM; Patchefsky A; Hanks GE
Cancer; 1998 Aug; 83(4):753-9. PubMed ID: 9708941
[TBL] [Abstract][Full Text] [Related]
2. Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings.
Karram S; Trock BJ; Netto GJ; Epstein JI
Am J Surg Pathol; 2011 Sep; 35(9):1351-5. PubMed ID: 21836493
[TBL] [Abstract][Full Text] [Related]
3. Clinical and cost impact of second-opinion pathology. Review of prostate biopsies prior to radical prostatectomy.
Epstein JI; Walsh PC; Sanfilippo F
Am J Surg Pathol; 1996 Jul; 20(7):851-7. PubMed ID: 8669533
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of performing immunohistochemistry on cases with a previous diagnosis of cancer coming to a national comprehensive cancer center for treatment or second opinion.
Wetherington RW; Cooper HS; Al-Saleem T; Ackerman DS; Adams-McDonnell R; Davis W; Ehya H; Patchefsky AS; Suder J; Young NA
Am J Surg Pathol; 2002 Sep; 26(9):1222-30. PubMed ID: 12218579
[TBL] [Abstract][Full Text] [Related]
5. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.
Coblentz TR; Mills SE; Theodorescu D
Cancer; 2001 Apr; 91(7):1284-90. PubMed ID: 11283928
[TBL] [Abstract][Full Text] [Related]
6. Gleason grading challenges in the diagnosis of prostate adenocarcinoma: experience of a single institution.
Chen SD; Fava JL; Amin A
Virchows Arch; 2016 Feb; 468(2):213-8. PubMed ID: 26563400
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
8. Gleason score 3 + 4=7 prostate cancer with minimal quantity of gleason pattern 4 on needle biopsy is associated with low-risk tumor in radical prostatectomy specimen.
Huang CC; Kong MX; Zhou M; Rosenkrantz AB; Taneja SS; Melamed J; Deng FM
Am J Surg Pathol; 2014 Aug; 38(8):1096-101. PubMed ID: 24832163
[TBL] [Abstract][Full Text] [Related]
9. Perineural invasion on biopsy is associated with upstaging at radical prostatectomy in Gleason score 3 + 4 = 7 prostate cancer.
Flood TA; Schieda N; Keefe DT; Morash C; Bateman J; Mai KT; Belanger EC; Robertson SJ; Breau RH
Pathol Int; 2016 Nov; 66(11):629-632. PubMed ID: 27709739
[TBL] [Abstract][Full Text] [Related]
10. Effects of perineural invasion in prostate needle biopsy on tumor grade and biochemical recurrence rates after radical prostatectomy.
Celik S; Bozkurt O; Demir O; Gurboga O; Tuna B; Yorukoglu K; Aslan G
Kaohsiung J Med Sci; 2018 Jul; 34(7):385-390. PubMed ID: 30063011
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Gleason score 3 + 4 = 7 prostate cancer with minimal amounts (<6%) vs ≥6% of Gleason pattern 4 tissue in needle biopsy specimens.
Kır G; Seneldir H; Gumus E
Ann Diagn Pathol; 2016 Feb; 20():48-51. PubMed ID: 26750655
[TBL] [Abstract][Full Text] [Related]
12. The value of mandatory second opinion pathology review of prostate needle biopsy interpretation before radical prostatectomy.
Brimo F; Schultz L; Epstein JI
J Urol; 2010 Jul; 184(1):126-30. PubMed ID: 20478583
[TBL] [Abstract][Full Text] [Related]
13. Perineural invasion detection in prostate biopsy is related to recurrence-free survival in patients submitted to radical prostatectomy.
Katz B; Srougi M; Dall'Oglio M; Nesrallah AJ; Sant'anna AC; Pontes J; Antunes AA; Reis ST; Viana N; Sañudo A; Camara-Lopes LH; Leite KR
Urol Oncol; 2013 Feb; 31(2):175-9. PubMed ID: 21795075
[TBL] [Abstract][Full Text] [Related]
14. The importance of histopathologic review of biopsies in patients with prostate cancer referred to a tertiary uro-oncology center.
Matheus WE; Ferreira U; Brandão EA; Ferruccio AA; Billis A
Int Braz J Urol; 2019; 45(1):32-37. PubMed ID: 30521172
[TBL] [Abstract][Full Text] [Related]
15. Gleason scoring at a comprehensive cancer center: what's the difference?
Townsend NC; Ruth K; Al-Saleem T; Horwitz EM; Sobczak M; Uzzo RG; Viterbo R; Buyyounouski MK
J Natl Compr Canc Netw; 2013 Jul; 11(7):812-9. PubMed ID: 23847218
[TBL] [Abstract][Full Text] [Related]
16. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.
Quinn DI; Henshall SM; Brenner PC; Kooner R; Golovsky D; O'Neill GF; Turner JJ; Delprado W; Grygiel JJ; Sutherland RL; Stricker PD
Cancer; 2003 Apr; 97(8):1884-93. PubMed ID: 12673714
[TBL] [Abstract][Full Text] [Related]
18. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
Kupelian P; Kuban D; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):415-9. PubMed ID: 15667961
[TBL] [Abstract][Full Text] [Related]
19. Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosis.
Ellis CL; Partin AW; Han M; Epstein JI
J Urol; 2013 Dec; 190(6):2068-73. PubMed ID: 23727307
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of perineural invasion in prostatic cancer biopsies: a systematic review.
Harnden P; Shelley MD; Clements H; Coles B; Tyndale-Biscoe RS; Naylor B; Mason MD
Cancer; 2007 Jan; 109(1):13-24. PubMed ID: 17123267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
